Challenges and considerations in the immunotherapy of DLL3-positive small-cell lung cancer using IL-18 armoured chimeric antigen receptor T-cells

Research output: Contribution to journalEditorialpeer-review

Original languageEnglish
Pages (from-to)678-683
Number of pages6
JournalTranslational Lung Cancer Research
Volume13
Issue number3
DOIs
Publication statusPublished - 1 Apr 2024

Cite this